Female-controlled dual protection methods: Prevalence, predictors, experiences and perceptions among young women living with HIV in northern Uganda-A mixed-method study protocol.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 29 03 2023
accepted: 04 08 2023
medline: 11 10 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: epublish

Résumé

The use of dual protection methods among young women living with HIV (YWLHIV) aged 15-24 years in sub-Saharan Africa (SSA) is poorly researched despite the double risk of unintended pregnancy and HIV. Even more scanty is literature on the use of female-controlled dual protection methods. We propose to determine the female-controlled dual protection prevalence, and the predictors among YWLHIV in northern Uganda. The study will also explore the YWLHIV's experiences and perceptions regarding the female-controlled dual protection methods. This study will employ a mixed-methods design. The study area will be Lira district and Lira city located in northern Uganda. The setting for recruitment of participants will be the public health facility-based anti-retroviral therapy (ART) clinics. These ART clinics serves a total of about 1,771 YWLHIV. A sample of 425 YWLHIV will be selected by stratified random sampling from the ART clinic registers. The three strata of interest will be the YWLHIV attending the ART clinic at referral hospitals, health centers level IV (primary healthcare centers), and health centers level III (dispensaries). The primary outcome will be the use of the female-controlled dual protection methods. The outcome will be measured by asking the YWLHIV 'what methods under their control as YWLHIV do they use to protect against both unintended pregnancy and HIV during sexual intercourse with their male partners.' The questionnaire also has measures for the unintended pregnancy, HIV status, and the potential predictors. Qualitative component of the study will be in-depth interviews of the participants about their experiences and perceptions regarding the female-controlled dual protection methods. Data collection was still ongoing at the time of first submission of this study protocol to the journal (14th March 2023). The Statistical Package for Social Sciences (SPSS) version 23.0 will be used for the statistical analyses. Descriptive statistics, bivariate and multivariate regression analyses will be used to establish the prevalence, associated factors and the predictors of the outcome respectively. The statistical significance level of 5% and 95% confidence interval will be considered. In-depth interviews will be manually analyzed using a thematic analysis approach for codes, themes, and categories.

Sections du résumé

STUDY BACKGROUND
The use of dual protection methods among young women living with HIV (YWLHIV) aged 15-24 years in sub-Saharan Africa (SSA) is poorly researched despite the double risk of unintended pregnancy and HIV. Even more scanty is literature on the use of female-controlled dual protection methods. We propose to determine the female-controlled dual protection prevalence, and the predictors among YWLHIV in northern Uganda. The study will also explore the YWLHIV's experiences and perceptions regarding the female-controlled dual protection methods.
MATERIALS AND METHODS
This study will employ a mixed-methods design. The study area will be Lira district and Lira city located in northern Uganda. The setting for recruitment of participants will be the public health facility-based anti-retroviral therapy (ART) clinics. These ART clinics serves a total of about 1,771 YWLHIV. A sample of 425 YWLHIV will be selected by stratified random sampling from the ART clinic registers. The three strata of interest will be the YWLHIV attending the ART clinic at referral hospitals, health centers level IV (primary healthcare centers), and health centers level III (dispensaries). The primary outcome will be the use of the female-controlled dual protection methods. The outcome will be measured by asking the YWLHIV 'what methods under their control as YWLHIV do they use to protect against both unintended pregnancy and HIV during sexual intercourse with their male partners.' The questionnaire also has measures for the unintended pregnancy, HIV status, and the potential predictors. Qualitative component of the study will be in-depth interviews of the participants about their experiences and perceptions regarding the female-controlled dual protection methods. Data collection was still ongoing at the time of first submission of this study protocol to the journal (14th March 2023). The Statistical Package for Social Sciences (SPSS) version 23.0 will be used for the statistical analyses. Descriptive statistics, bivariate and multivariate regression analyses will be used to establish the prevalence, associated factors and the predictors of the outcome respectively. The statistical significance level of 5% and 95% confidence interval will be considered. In-depth interviews will be manually analyzed using a thematic analysis approach for codes, themes, and categories.

Identifiants

pubmed: 37812632
doi: 10.1371/journal.pone.0290338
pii: PONE-D-23-07574
pmc: PMC10561857
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0290338

Informations de copyright

Copyright: © 2023 Kumakech et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2012 Aug 2;367(5):423-34
pubmed: 22784038
Sci Rep. 2020 Oct 1;10(1):16319
pubmed: 33004969
N Engl J Med. 2012 Aug 2;367(5):411-22
pubmed: 22784040
J Int AIDS Soc. 2021 Jun;24(6):e25670
pubmed: 34152067
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
Indian J Psychol Med. 2013 Apr;35(2):121-6
pubmed: 24049221
BMC Womens Health. 2020 Apr 22;20(1):78
pubmed: 32321480
BMJ Open. 2018 Apr 3;8(4):e019979
pubmed: 29615449
Contraception. 2016 Jul;94(1):11-7
pubmed: 27018154
BMC Womens Health. 2018 Feb 27;18(1):46
pubmed: 29486752
Reprod Health. 2018 Oct 24;15(1):180
pubmed: 30355344
J Int AIDS Soc. 2020 Sep;23 Suppl 5:e25558
pubmed: 32869543
J Int AIDS Soc. 2022 Jan;25(1):e25872
pubmed: 35030296
Sex Transm Dis. 2002 Mar;29(3):168-74
pubmed: 11875378
J Int AIDS Soc. 2022 May;25(5):e25942
pubmed: 35633097
J Infect Dis. 2005 May 1;191(9):1403-9
pubmed: 15809897
Front Reprod Health. 2021 Jul 14;3:684114
pubmed: 36304059
PLoS One. 2021 Sep 10;16(9):e0257321
pubmed: 34506577
Soc Sci Med. 2022 Jan;292:114523
pubmed: 34785096
PLoS One. 2019 Aug 9;14(8):e0220970
pubmed: 31398240
Biomed Res Int. 2018 Jan 28;2018:7375831
pubmed: 29789804
J Womens Health (Larchmt). 2017 Aug;26(8):900-910
pubmed: 28829720
AIDS Educ Prev. 2018 Oct;30(5):369-381
pubmed: 30332306
PLoS One. 2018 Oct 25;13(10):e0206325
pubmed: 30359430
AIDS. 2022 Feb 1;36(2):267-276
pubmed: 34342294
Front Psychol. 2015 Feb 05;6:87
pubmed: 25699002
BMC Public Health. 2016 Jan 16;16:44
pubmed: 26774918
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
BMJ Glob Health. 2022 Mar;7(3):
pubmed: 35332057
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
BMC Womens Health. 2012 Oct 06;12:34
pubmed: 23039966
J Infect Dis. 2012 Feb 1;205(3):358-65
pubmed: 22241800
Drugs. 2015 Feb;75(3):243-51
pubmed: 25673022
PLoS One. 2020 Apr 23;15(4):e0230823
pubmed: 32324764

Auteurs

Edward Kumakech (E)

Department of Nursing, Faculty of Nursing and Midwifery, Lira University, Lira City, Uganda.

Joy Acen (J)

Department of Midwifery, Faculty of Nursing and Midwifery, Lira University, Lira City, Uganda.

Marvin Musinguzi (M)

Department of Community Health, Faculty of Public Health, Lira University, Lira City, Uganda.

Doryn Ebong (D)

Department of Nursing and Midwifery, Lira Regional Referral Hospital, Lira City, Uganda.

James Okello (J)

Department of Obstetrics and Gynecology, Lira Regional Referral Hospital, Lira City, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH